uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Experimenter gender and replicability in science
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.ORCID iD: 000-0002-8911-4068
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Functional Pharmacology.ORCID iD: 0000-0001-7112-0921
2018 (English)In: Science Advances, E-ISSN 2375-2548, Vol. 4, no 1, article id e1701427Article, review/survey (Refereed) Published
Abstract [en]

There is a replication crisis spreading through the annals of scientific inquiry. Although some work has been carried out to uncover the roots of this issue, much remains unanswered. With this in mind, this paper investigates how the gender of the experimenter may affect experimental findings. Clinical trials are regularly carried out without any report of the experimenter's gender and with dubious knowledge of its influence. Consequently, significant biases caused by the experimenter's gender may lead researchers to conclude that therapeutics or other interventions are either overtreating or undertreating a variety of conditions. Bearing this in mind, this policy paper emphasizes the importance of reporting and controlling for experimenter gender in future research. As backdrop, it explores what we know about the role of experimenter gender in influencing laboratory results, suggests possible mechanisms, and suggests future areas of inquiry.

Place, publisher, year, edition, pages
2018. Vol. 4, no 1, article id e1701427
National Category
Neurosciences Psychology (excluding Applied Psychology)
Identifiers
URN: urn:nbn:se:uu:diva-352930DOI: 10.1126/sciadv.1701427ISI: 000426694200010OAI: oai:DiVA.org:uu-352930DiVA, id: diva2:1215658
Funder
Swedish Research CouncilAvailable from: 2018-06-08 Created: 2018-06-08 Last updated: 2019-03-15Bibliographically approved

Open Access in DiVA

fulltext(276 kB)50 downloads
File information
File name FULLTEXT01.pdfFile size 276 kBChecksum SHA-512
b92307c4a1138a4425c19bdeb214c461afb737435429be77060694cda3d68c1e18c57f146ebab256cdfa930423ad278c5d548c007783ada8c056053a06fc2afd
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Chapman, Colin DanielBenedict, ChristianSchiöth, Helgi B.

Search in DiVA

By author/editor
Chapman, Colin DanielBenedict, ChristianSchiöth, Helgi B.
By organisation
Functional Pharmacology
In the same journal
Science Advances
NeurosciencesPsychology (excluding Applied Psychology)

Search outside of DiVA

GoogleGoogle Scholar
Total: 50 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 90 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf